Catch up with all FIP previous webinars and digital events.
The role of pharmacist in closing the gender pain gap
Research has shown that women may receive less intensive, less effective and lower quality treatment due to stereotyped responses attributed to women, such as dramatising, overemphasising their experiences of pain, being more willing to report pain, inaccurately reporting pain or being less tolerant to pain than men. It results in the underestimation and undertreatment of women’s pain worldwide. This is often referred to as the “gender pain gap”.
Regarding the gender pain gap, self-awareness and training are not issues owned only by pharmacists; they should be shared with all healthcare professionals and the public.
Pharmacists can be supported to address the gender pain gap through education and partnerships. Good understanding of the variety of pain symptoms can support unbiased pain management. Pharmacists also have a responsibility to educate the public on where and how to seek help for pain management, thus further addressing the gender pain gap.
The event aims to
- Define the gender pain gap
- Increase awareness about gender pain gap
- Describe how pharmacists can be supported to address the issue
- Describe the knowledge and training for pharmacists to close the gender pain gap
Learning objectives:
- Understand the gender inequalities in pain research
- Increase their awareness of gender gap in treatment offers for pain management
- Describe knowledge and training status on unconscious bias towards women in pain management
- Define knowledge, attitudes and practices that pharmacists have, to close the gender pain gap
- Describe how pharmacists can be supported with e.g. training, tools to address gender inequalities in pain management, bring close the gender pain gap, achieve behavioural change towards women
Chair:
- Parisa Aslani, Professor, The University of Sydney School of Pharmacy, Australia
Facilitator:
- Aysu Selcuk, FIP Education and Primary Health Care Policies Specialist, The Netherlands
Panellists:
- Catherine Duggan, FIP CEO, The Netherlands
- Jonathan Penm, Senior lecturer, The University of Sydney School of Pharmacy, Australia
- Jack Collins, Postdoctoral Research Associate, The University of Sydney, Australia
- Leticia Caligaris, Community pharmacist lead, Executive committee member, member of Pharmacist Association of Uruguay
- Miranda Sertic, Associate Professor, Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia
- Roger Knaggs, Associate Professor in Clinical Pharmacy Practice, University of Nottingham, UK